WATSON 3330 (Cyclobenzaprine hydrochloride 7.5 mg)
Pill imprint WATSON 3330 has been identified as Cyclobenzaprine hydrochloride 7.5 mg.
Cyclobenzaprine is used in the treatment of muscle spasm; sciatica; chronic myofascial pain; fibromyalgia; migraine (and more), and belongs to the drug class skeletal muscle relaxants. There is no proven risk in humans during pregnancy. Cyclobenzaprine 7.5 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 7.5 mg
- 8.00 mm
- Prescription only
calcium phosphate dibasic anhydrous
|NDC Code||Manufacturer / Repackager|
|18837-0285||Innoviant Pharmacy Inc (repackager)|
|16590-0699||Stat RX USA LLC (repackager)|
Note: Inactive ingredients may vary.
More about cyclobenzaprine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.